Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Laura B Freeman

Pooled Investigation of Pesticides and Lymphoma and Multiple Myeloma and Immunoproliferative Diseases in NCI and Cross-Canada Case-Control Studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

William Figg

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

Thymus Prostate Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Prostate Pancreas Non-Hodgkin lymphoma Nasopharynx Multiple myeloma and immunoproliferative diseases Melanoma of skin Leukaemia Colorectum Breast Bladder

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Antoinette Stroup

PATTERNS OF CARE/QUALITY OF CARE STUDY : DIAGNOSIS YEAR 2014

Multiple myeloma and immunoproliferative diseases Leukaemia Colorectum

Ralph D Sanderson

Novel Heparanase Inhibitors for Cancer Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology